//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts
Loading...
Video
New findings from the OrigAMI-4, a study led by Professor Kevin Harrington in advanced head and neck cancer are presented today at #ASCO2026 ⤵️ www.asco.org/abstracts-pr...
🎙️ICR's Professor Kevin Harrington spoke to Naga Munchetty and Chris Smith on @bbc5live.bsky.social He spoke about how the early discoveries were made that viruses could infect tumours, and how this has led to modern, genetically engineered viruses to treat cancer - called oncolytic virotherapy.
3d
13d
Making clinical trials more inclusive isn’t just about fairness; it’s about better science. By widening access and considering underserved groups from the outset, researchers can build stronger evidence and help ensure that new cancer treatments work for everyone who needs them.
5d